Dare Bioscience, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Dare Bioscience, Inc. (DARE) is -5860290.00

According to Dare Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -5860290.00. This represents a change of -156.76% compared to the average of 10.32M of the last 4 quarters.

Dare Bioscience, Inc. (DARE) Historical Enterprise Value (quarterly & annually)

How has DARE Enterprise Value performed in the past?

The mean historical Enterprise Value of Dare Bioscience, Inc. over the last ten years is 59.12M. The current -5860290.00 Enterprise Value has changed -1091.24% with respect to the historical average. Over the past ten years (40 quarters), DARE's Enterprise Value was at its highest in in the December 2017 quarter at 83.93B. The Enterprise Value was at its lowest in in the March 2018 quarter at -8351720.40.

Dare Bioscience, Inc. (DARE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dare Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dare Bioscience, Inc. (DARE) Average Enterprise Value

How has DARE Enterprise Value performed in the past?

The current Enterprise Value of Dare Bioscience, Inc. (DARE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Dare Bioscience, Inc. (DARE) Enterprise Value vs. Peers

How is DARE’s Enterprise Value compared to its peers?

Dare Bioscience, Inc.’s Enterprise Value is less than FibroBiologics, Inc. Common Stock (2.37M), less than Citius Pharmaceuticals, Inc. (2.58M), less than Leap Therapeutics, Inc. (27.39M), less than Ainos, Inc. (16.95M), less than Athira Pharma, Inc. (-4376050.00), less than Aspire Biopharma Holdings, Inc. (-3710573.00), less than Aditxt, Inc. (6.66M), less than Palisade Bio, Inc. (207.59M), less than Adlai Nortye Ltd. (645.39M), less than Hoth Therapeutics, Inc. (12.90M),

Build a custom stock screener for Dare Bioscience, Inc. (DARE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dare Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dare Bioscience, Inc. (DARE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dare Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.